Age-dependent changes at the blood-brain barrier: a comparative structural and functional study in young adult and middle aged rats by Bors, Luca Anna et al.
Accepted Manuscript
Title: Structural and functional characterization of
age-associated changes at the blood-brain barrier. A
comparative in vivo study in young adult and middle aged
Wistar rats
Authors: Luca Bors, Kinga To´th, Estilla Zso´fia To´th, ´Agnes
Bajza, Attila Csorba, Krisztia´n Szigeti, Domokos Ma´the´,
Ga´bor Perlaki, Gergely Orsi, Ga´bor K. To´th, Franciska Erdo˝
PII: S0361-9230(18)30014-5
DOI: https://doi.org/10.1016/j.brainresbull.2018.03.001
Reference: BRB 9387
To appear in: Brain Research Bulletin
Received date: 9-1-2018
Revised date: 22-2-2018
Accepted date: 2-3-2018
Please cite this article as: Luca Bors, Kinga To´th, Estilla Zso´fia To´th, ´Agnes Bajza, Attila
Csorba, Krisztia´n Szigeti, Domokos Ma´the´, Ga´bor Perlaki, Gergely Orsi, Ga´bor K.To´th,
Franciska Erdo˝, Structural and functional characterization of age-associated changes
at the blood-brain barrier.A comparative in vivo study in young adult and middle aged
Wistar rats, Brain Research Bulletin https://doi.org/10.1016/j.brainresbull.2018.03.001
This is a PDF file of an unedited manuscript that has been accepted for publication.
As a service to our customers we are providing this early version of the manuscript.
The manuscript will undergo copyediting, typesetting, and review of the resulting proof
before it is published in its final form. Please note that during the production process
errors may be discovered which could affect the content, and all legal disclaimers that
apply to the journal pertain.
1 
 
Structural and functional characterization of age-associated 
changes at the blood-brain barrier. A comparative in vivo study in 
young adult and middle aged Wistar rats. 
 
Running title: Aging and the blood-brain barrier 
 
Luca Borsa, Kinga Tóthb, Estilla Zsófia Tóthb, Ágnes Bajzaa, Attila Csorbac, Krisztián 
Szigetid, Domokos Máthéd,e, Gábor Perlakif,g, Gergely Orsif,g, Gábor K. Tóthh and Franciska 
Erdőa 
 
aPázmány Péter Catholic University, Faculty of Information Technology and Bionics, Práter 
u. 50a, H-1083 Budapest 
bHungarian Academy of Sciences, Institute of Cognitive Neuroscience and Psychology, 
Magyar tudósok körútja 2. H-1117 Budapest 
cUniversity of Szeged, Faculty of Pharmacy, Deparment of Pharmacognosy, Eötvös u. 6, H-
6720 Szeged 
dSemmelweis University, Faculty of Medicine, Department of Biophysics and Radiation 
Biology, Tűzoltó u. 37-47, H-1094 Budapest 
eCROmed Translational Research Ltd. Budapest 
fMTA-PTE Clinical Neuroscience MR Research Group, Ret u. 2, H-7623 Pecs, Hungary, 
gDepartment of Neurosurgery, University of Pecs, Medical School, Ret u. 2, H-7623 Pecs, 
Hungary 
hDepartment of Medical Chemistry, Faculty of Medicine, University of Szeged, Dóm tér 8, H-
6720, Szeged, Hungary. 
 
Corresponding author:  
Franciska Erdő, PhD 
Pázmány Péter Catholic University, Faculty of Information Technology and Bionics 
Práter u. 50/a, H-1083 Budapest, Hungary 
e-mail: erdo.franciska@itk.ppke.hu 
tel: +36/20-3541-081 
 
AC
CE
PT
ED
 M
AN
US
CR
IPT
2 
 
Graphical abstract 
 
 
Highlights 
 There are structural changes at the blood-brain barrier (BBB) with aging 
 Microdialysis and SPECT data suggest reduced function of P-pg at the BBB with aging 
 Immunohistochemistry revealed a reduced expression of P-gp in the brain with aging 
 The brain exposure to quinidine after P-gp inhibition increased more in young rats 
 
Abstract 
Decreased beta-amyloid clearance in Alzheimer’s disease and increased blood-brain barrier 
permeability in aged subjects have been reported in several articles. However, morphological and 
functional characterization of blood-brain barrier and its membrane transporter activity have not 
been described in physiological aging yet. The aim of our study was to explore the structural changes 
in the brain microvessels and possible functional alterations of P-glycoprotein at the blood-brain 
barrier with aging. Our approach included MR imaging for anatomical orientation in middle aged rats, 
electronmicroscopy and immunohistochemistry to analyse the alterations at cellular level, dual or 
triple-probe microdialysis and SPECT to test P-glycoprotein functionality in young and middle aged 
rats. Our results indicate that the thickness of basal lamina increases, the number of tight junctions 
decreases and the size of astrocyte endfeet extends with advanced age. On the basis of microdialysis 
and SPECT results the P-gp function is reduced in old rats. With our multiparametric approach a 
complex regulation can be suggested which includes elements leading to increased permeability of 
blood-brain barrier by enhanced paracellular and transcellular transport, and factors working against 
it. To verify the role of P-gp pumps in brain aging further studies are warranted. 
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1. Introduction 
Blood-brain barrier (BBB) dysfunction might be an important component of many neurodegenerative 
disorders like Alzheimer’s disease (Zlokovic 2011, Erdő et al., 2017), Parkinson’s disease (Gray and 
Woulfe 2015, Pisani, et al., 2012, Erdő et al., 2017), stroke (Ronaldson and Davis 2012, Sandoval and 
Witt 2008), pharmacoresistant epilepsy (Sahin, et al., 2003, Ndode-Ekane, et al., 2010) and multiple 
sclerosis (Alvarez etal., 2011, Holman et al., 2011). Many of these diseases have an age-related 
progression. However, in the process of healthy aging there might also be an increased „leakage” of 
BBB not only by the alteration of endothelial cells, thickness of basal lamina, and morphology of 
pericytes and astrocytes, but also due to the changes in expression of different transporter proteins 
at the endothelial cell layer of BBB. The aim of our study was therefore, to investigate the 
morphological and functional consequences of advanced age on the blood-brain barrier during the 
process of physiological aging in healthy rats. This study has a special focus on P-glycoprotein (P-gp, 
ABCB1/MDR1, Abcb1a/Mdr1a), (the most important efflux transporter) functionality located on the 
luminal surface of brain capillary endothelial cells. For this approach different techniques were used 
such as electronmicroscopy and immunohistochemistry for evaluation of morphology and glial 
fibrillar acidic protein (GFAP) and efflux transporter protein expression; magnetic resonance imaging 
(MRI) to study macroscopic anatomical alterations of the brain; brain and blood microdialysis to test 
efflux transporter functions and single photon emission computed tomography (SPECT) imaging also 
for investigation P-gp efflux transporter functionality at the BBB. 
ABC: ATP-binding casette  
aCSF: artificial cerebrospinal fluid 
AP: Anterior-posterior 
aPPF: artificial peripheral perfusion fluid 
AUC: Area under the curve 
BBB: Blood-Brain Barrier 
Cmax: Maximum concentration 
DMSO: Dimethyl sulfoxide 
DV: Dorso-vetral 
FOV: Field of view 
GFAP: Glial fibrillar acidic protein 
HESI: Heated Electrospray Ionization 
HPLC: High-performance liquid chromatography 
IV: Intra-venous 
LCMS-MS: Liquid cromatography - tandem Mass Spectrometry 
LV: Lateral ventricle 
MDR: Multidrug resistance 
MIBI: Methoxy-isobutyl-isonitrile 
ML: Midline 
MRI: Magnetic resonance imaging 
NGS: Normal Goat Serum 
NHS: Normal Horse Serum 
PB: Phosphate buffer 
P-gp: P-glycoprotein  
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PRM: Parallel reaction monitoring 
RF: Radiofrequency 
SPECT: Single photon emission computed tomography 
STR: Striatum 
TJ: Tight junctions 
TR / TE: Repetition time / Echo time 
 
2. Materials and Methods 
2.1 Comparative MRI in young adult and middle aged rats 
MRI was performed on a 3T human MRI scanner (MAGNETOM Trio a Tim System, Siemens AG, 
Erlangen, Germany) using a loop RF coil with an inner diameter of 40 mm (Siemens Medical 
Solutions, Erlangen, Germany) and a custom-built head holder (Aradi, et al., 2011). T2-weighted 
images were obtained in three different orientations (i.e. axial, sagittal, coronal) using the following 
2D turbo-spin echo sequence: TR/TE=5270/99 ms; 26 slices; slice thickness=1 mm; FOV=34x34 mm2; 
matrix size=192x192 interpolated to 384x384; bandwidth=40 Hz/pixel; turbo factor=8; averages=2. 
2.2 Immunohistochemistry 
The rats were deeply anesthetized with a high dose of ketamine/xylazine cocktail and transcardially 
perfused first with physiological saline (3 min), then a fixative containing 4% paraformaldehyde and 
15% picric acid in 0.1 M phosphate buffer (PB) (30 min). 
60-μm-thick coronal sections were cut from the fixed brain and processed for immunostaining. The 
P-gp immunostaining was performed according to Volk and coworkers (Volk etal., 2005). In brief, the 
sections were pre-treated with a mixture of 33% acetic acid and 66% ethanol (10 min, -20 ⁰C), 
followed by the blocking of the endogenous peroxidase enzyme by 0.6% H2O2 (30 min) and the 
blocking of the non-specific immunoglobulin binding of the tissue (60 min) by a mixture of 3% Bovine 
Serum Albumin (Sigma-Aldrich, St. Louis, MO, USA) and 10 % NHS (Normal Horse Serum, Vector 
Laboratories, Burlingame, CA, USA). The GFAP-immunostaining protocol was performed as described 
by Grand et al (Grand et al. 2010) with minor modifications (see below). These sections were pre-
treated by 1% H2O2, followed by a mixture of 2% NGS (Normal Goat Serum, Vector Laboratories, 
Burlingame, CA, USA) and NHS. 
A monoclonal mouse antibody against GFAP (1:2000, EMD Millipore MAB3402, clone GA5, Billerica, 
MA, USA) or a monoclonal mouse antibody against P-Glycoprotein (P-gp, 1 µg/ml, EMD Millipore 
MAB517310, clone C219, Billerica, MA, USA) was used as a primary antibody. For the visualization of 
immunopositive elements, biotinylated anti-mouse immunoglobulin G (1:250, Vector Laboratories) 
was applied as secondary serum, followed by avidin-biotinylated horseradish peroxidase complex 
(1:250, Vector Laboratories). The sections were preincubated in 3,30-diaminobenzidine-
tetrahydrochloride chromogen (0.05%, Sigma-Aldrich) and then developed by 0.01% H2O2. The P-gp-
immunostained sections were mounted, dehydrated for light microscopy (2x10 min in xylene) and 
coverslipped with DePeX (Serva Electrophoresis GmbH, Heidelberg, Germany). The GFAP-
immunostained sections were osmicated (0.5%, Electron Microscopy Sciences, Hatfield, PA, USA), 
dehydrated in ethanol and mounted in Durcupan (Sigma-Aldrich) for further light- and electron 
microscopic examination. (For more details see: Grand and co-workers, 2010 (Grand et al., 2010)). 
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2.3 Comparative electronmicroscopy of brain microvasculature of young and 
middle aged rats  
The electron microscopic examination of the blood brain barrier was carried out on two animals (1 
young and 1 old adult). The GFAP-stained sections were used. A 400x400 µm2 region was re-
embedded from the striatum of both specimens under light microscopic control and sectioned for 
electron microscopy. Ultrathin serial sections were collected on Formvar-coated single slot grids, 
stained with lead citrate and examined in a Hitachi 7100 electron microscope. Low- and high 
magnification (1,000x – 30,000x) electron micrographs were taken of the capillaries (n=7 and n=5 in 
young- and old animals, respectively). 
2.4 Comparative investigation of P-gp function at the BBB in young adult and 
middle aged rats by in vivo microdialysis 
2.4.1 Animals, surgical procedures, and drug administration 
Male Wistar rats (ToxiCoop, Budapest, Hungary) 2-3 months (young adult) or 14-16 months (middle 
aged) were used throughout the experiments and had free access to food and water. CMA/20 
peripheral probes were implanted in the jugular vein, and the rats were then placed in a stereotaxic 
frame for implantation of CMA/12 brain probes in the striatum (STR) or in the lateral ventricle (LV) 
for performing the microdialysis experiments under chloral hydrate anesthesia (400 mg/kg, 
intraperitoneal) (Sziráki et al., 2011). The stereotaxic coordinates for STR with respect to the bregma 
in young rats were AP = +0.20 mm, ML = +3.8, and DV = –7.4. In middle aged rats the position for the 
STR probe was AP: +0.3 mm, ML: +3.5 mm and DV: -7.5 mm. An additional probe (CMA/12 1 mm 
membrane) was placed into the LV in the opposite hemisphere to the STR probe in middle aged rats 
at AP: -1.0 mm, ML: +1.5, DV: -4.0 mm coordinates. Anesthesia during the surgical procedures or the 
microdialysis experiments was maintained by further injections of chloral hydrate as needed. 
Quinidine (Sigma-Hungary Kft, Budapest, Hungary, 5 mg/kg), the ABCB1 inhibitor PSC-833 (a gift from 
Prof. Gábor Tóth, University of Szeged, Hungary, 2x2 mg/kg) and vehicle for the inhibitor were 
administered intravenously (2 mL/kg bodyweight) via a catheter implanted in the femoral vein. All 
animal experiments were performed in full compliance with the guidelines of the Association for 
Assessment and Accreditation of Laboratory Animal Care International’s expectations for animal use, 
per the spirit of the licence issued by the Directorate for the Safety of the Food Chain and Animal 
Health, Budapest and Pest County Agricultural Administrative Authority, Hungary.  
2.4.2 Microdialysis procedures and sampling. 
Animals were sampled from 60 min before till 240 min after intravenous (IV) dosing of quinidine. The 
peripheral and central probes were perfused with artificial peripheral perfusion fluid (aPPF) or 
artificial cerebrospinal fluid (aCSF) at a flow rate of 1.0 μL/min using a CMA 102 microdialysis pump. 
Samples were collected in polyethylene microtubes and placed on dry ice at the end of each 
collection period. After completing an experiment, the blood and brain dialysates were transferred to 
a deep freezer and kept at –70°C. Dialysate samples were later transferred to a bioanalytical 
laboratory and analyzed for concentrations of quinidine by LCMS-MS.  
2.4.3 Data analysis of in vivo experiments. 
Unpaired Student’s t-test was performed on areas under the curve (AUCs) of concentration-time 
profiles, maximum concentrations (Cmax values), individual concentration values and brain-to-blood 
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ratios for testing possible age-dependent differences in concentrations of dialysate samples by the 
advanced age. The statistical analysis was performed by Microsoft Excel 2010. 
At electromicroscopy the following parameters were examined: i) capillary wall thickness (as a ratio 
of the inner and outer perimeter of the vessel); ii) thickness of the basal membrane in spots of 0.5 
µm distance from each other along the outer perimeter (281 spots in young and 259 spots in old 
adults); iii) area of the astrocyte endfeet profiles (normalized to area of the capillary wall); iv) area of 
the pericyte profiles (normalized to area of the capillary wall); v) number and length of the TJs 
(normalized to area of the capillary wall). For the statistical analysis, the nonparametric Mann-
Whitney U test was applied. Differences were considered to be significant at probability values lower 
than 0.05. 
2.5 LC-MS/MS for bioanalysis of dialysate samples 
The quantitative analysis of the dialysate samples was performed on Agilent 1100 HPLC system 
(Santa Clara, USA) coupled with Thermo Scientific Q Exactive Plus orbitrap mass spectrometer 
(Waltham, MA USA). The HPLC consisted of binary pump, thermostated autosampler and 
thermostated column compartment. The column used was Kinetex XB-C18 (particle size 2.6 µm, pore 
size 100 Å, length/diameter in mm: 50/2.1) from Phenomenex (Gen-Lab Kft., Budapest, Hungary). 
The isocratic eluent was mixed by the HPLC pump at 0.5 ml/min flow rate in 92/8 % A/B ratio where 
eluent A and B was MS grade water and acetonitrile, respectively, both containing 0.1 % formic acid 
(VWR International Kft., Debrecen, Hungary). The analysis time was 2.5 minutes. The mass 
spectrometer operated in positive PRM mode with HESI source (spray voltage: 3500 V, capillary 
temperature: 300 °C, sheath gas/auxiliary gas/spare gas: 55/15/5 in arbitrary units, sheath gas 
temperature: 400 °C). The quantitation was done with the m/z: 79.0551 Da product ion with 5 ppm 
mass tolerance from the fragmentation of the m/z: 325.1910 Da mass at HCD: 50. 
The calibration samples were prepared by spiking aCSF solution in 1 % with the working standards. 
The stock solution had 100 mM concentration in DMSO, the working standards were diluted further 
in DMSO in 0.025, 0.05, 0.25, 0.5, 2.5, 5, 25, 50, 250, 500 µM concentration. The final concentration 
range of the calibration samples was 0.25-5000 nM. 
2.6 Comparative investigation of P-gp function at the BBB by SPECT imaging in 
young and middle aged rats 
SPECT image acquisition was performed in a NanoSPECT/CT Silver Upgrade system (Mediso, 
Budapest, Hungary) equipped with rat multi-pinhole apertures. Rats (one young animal as baseline 
and another young animal dosed with PSC833, one old animal as baseline and another old animal 
dosed with PSC833) were injected intravenously with [99mTechnetium]-2-methoxy-isobutyl-isonitrile 
(further referred to as MIBI) with a mean activity of 166.89 MBq. The precursor (Medi-MIBI kit, Medi-
Radiopharma Ltd. Érd Hungary) was radiolabeled with 99mTc-pertechnetate from a 99mTc-generator 
(Elumatic III, cisbio international, Gif-sur-Yvette, France) according to the manufacturer`s 
instructions. SPECT skull image acquisitions were started at 12, 24, 36, 48, 60, 72, 84, 96 108 and 120 
minutes post injection. The animal was anaesthetized with 4% isoflurane in medical oxygene while 
anaesthesia was maintained by 1.8% isoflurane inhalation. The animal was fixed in a Mediso 
MultiCell (Mediso, Budapest, Hungary) rat bed for exact positioning of the brain in the center of the 
SPECT field of view. Each SPECT 3D image acquisition took 10 minutes with 30 raw data acquisition 
steps. All ten three dimensional images of the skull region were reconstructed using Mediso 
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TeraTomo (Mediso, Budapest, Hungary) SPECT Monte-Carlo simulation based iterative 
reconstruction algorithm and radioactivity concentrations in MBq/mL were retrieved from the whole 
brain as region of interest from every SPECT 3D image. Region of interest (ROI) analysis and image 
processing was performed using the VivoQuant software (inviCRO, Boston, US). Brain ROI 
radioactivity in function of time and separately at the first two timepoints was then plotted for all 
scans using OriginPro 8 SR2. AUCs from timepoint 1 (12 min) through to timepoint 10 (120 minutes) 
were calculated for all 4 data sets using OriginPro 8 SR2.  
3. Results 
3.1 MR imaging 
The axial, coronal and sagittal images of the brains of a young and a middle aged animals were 
evaluated. A representative image from all the three orientations are shown in Figure 1. Comparing 
the size of the brains, the anterior-posterior extension increased by 14.8 %, the lateral extension by 
7.1 % and the dorso-ventral extension by 14.4 % with aging. At the same time the difference 
between the bodyweights was 3.12 fold. The extension of cerebral ventricles increased significantly 
with aging which makes the placement of a third microdialysis probe (beside the peripheral and 
striatal probes) possible exactly into the lateral vetricle in middle aged rats. Due to thickening of the 
parietal skull bone, the lateral coordiantes of the striatal microdialysis probes was modified in elderly 
animals from 3.8 to 3.5. 
 
3.2 Light microscopy 
P-gp plays an important role in the operation of the BBB by pumping foreign substances out of the 
endothelial cells (Sarkadi et al. 2006). Astroglial endfeet surrounding the brain capillaries contribute 
in the functioning of the BBB by providing biochemical support to endothelial cells (Abbott et al., 
2006) . 
Therefore, after the in vivo experiments, we sacrificed the animals and examined and compared the 
P-gp- and GFAP-staining in the young and middle aged adults. 
A moderate amount of astroglial cells and processes were visible in the neocortex (not shown) and in 
the striatum (Figure 2, A) of the young adult animals. In accordance with the literature (Middeldorp 
and Hol, 2011), both the amount of astroglial processes and their staining intensity seemed to be 
increased in the middle aged rats (Figure 2, B). 
The P-gp-staining confined to blood vessels in the brain tissues. In case of the young adult animals it 
was very intense, a high amount of capillaries were immunopositive (Figure2, C). As it is shown in 
Figure 2, D, the staining intensity was considerably lower in case of the middle aged animals, 
suggesting a lower expression of this efflux transporter protein by the increasing age (Silverberg et 
al., 2010). 
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3.3 Electronmicroscopy  
The ultrastructural composition of the blood brain barrier was altered in the old animal (Figure 3). 
The wall of the microvessels are composed of the regular elements, such as the endothelial cells 
connected by tight junctions (TJ), pericytes embedded in the basal membrane and the basal 
membrane which bounds the capillary from the side of the brain parenchima. The capillaries were 
surrounded by GFAP-immunopositive astroglial endfeet. 
The thickness of the capillary walls was calculated as a ratio of the inner and outer perimeter of the 
vessel to avoid getting false results due to measuring vessels of different size. Values nearing 1 depict 
a thin wall, whereas lower values depict a thicker wall. We found that the thickness of the capillary 
walls was significantly increased in the old animal (0.88±0.05 vs 0.57±0.14 in young and middle aged 
adults, respectively, p=0.0058) (Figure 3, A, B). 
The thickness of the basal membrane also increased significantly in case of the old animal (24.3±8.8 
nm vs 93.9±34.1 nm in young and middle aged adults, respectively, p=0.0001) (Figure 3, C-F). 
In the old animal, the area of the astrocyte endfeet profiles surrounding the capillaries was 
significantly higher, than in the young animal (3.54±3.42 µm2 vs 0.47±1.06 µm2; p=0.0001). The 
difference was statistically significant even after normalizing to the area of the capillary wall 
(1.58±1.14 vs 0.48±0.65; p=0.0348) (Figure 3, A, B). 
The amount of pericytes did not show any changes. The absolute values of perycite profile areas did 
not change (0.36±0.41 µm2 in young- and 0.54±0.44 µm2 in old animal; p=0.1012). Similarly the 
values normalized to the area of the capillary wall (0.15±0.04 vs 0.17±0.07 in young and middle aged 
adults, respectively, p=0.5698) did not significantly change. 
Finally, we examined the tight junctions and found a decreased amount between the endothelial 
cells in case of capillaries of the old animal. The average length of the TJs did not show a difference in 
the young and old animal (0.44±0.35 µm vs 0.41±0.51 µm; p=0.4038). However, both the number of 
TJs (0.35±0.29 vs 0.1±0.2; p=0.0740) and their total length per capillary (0.11±0.04 vs 0.04±0.06; 
p=0.0740) displayed a decreasing tendency in the old animal (values are normalized to area of the 
capillary wall), although the differences were not significant. 
 
In summary, the ultrastructural composition of the blood brain barrier changed in the old animal. The 
capillary walls and the basal membranes were thicker, the size of astrocyte endfeet around the 
vessels extended and the connection of endothelial cells by tight junctions displayed a decreasing 
tendency. 
3.4 LC-MS/MS results 
For determination of quinidine concentration in dialysate samples an LC-MS/MS method was 
developed. The calibration was accepted with R2 value higher than 0.995. The calibration model was 
non-linear due to the wide concentration range. The typical chromatograms are shown in Figure 4. 
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3.5 Microdialysis 
The concentration-time profiles of quinidine in the striatum, in the plasma and the lateral ventricle 
are shown in Figure 5. The AUCSTR/AUCblood ratio in control rats was 24.2 % (young) and 29.6 % (old), 
respectively. The brain exposure was higher in middle aged animals than in young ones in control 
groups (AUCSTR=124.82 vs 75.12 nM.h), but not in the PSC-833 treated groups (420.61 vs 530.96 
nM.h). In the groups of P-gp inhibitor treated animals the AUCSTR/AUCblood ratio was enhanced to 76.0 
% (young) and 91.0 % (old), respectively. The striatal concentrations of quinidine increased in a 
statistically significant manner both in young (p<0.05) and in middle aged (p<0.005) rats after the 
administration of the inhibitor as it is seen from the AUCSTR  values (Figure 5).. Also the elimination of 
the drug from the brain and blood shows a slower kinetics in the case of P-gp inhibition. The 
difference between the striatal concentration values of old and young controls was statically 
significant (p<0.05) at later timepoints (120 and 150 mins after QND treatment) (Figure 5A,C) 
reflecting to a higher, and longer lasting exposure to P-gp substrate with advanced age. The blood 
levels seemed also to be higher in aged than in the young subjects, but the difference was not 
statistically significant 
The different orientation of P-gp pump in the choroid plexus (blood –cerebrospinal fluid barrier, 
BSCFB) and in the BBB has been reported. (Shen et al., 2009, Krajcsi et al., 2012) At the BCSFB the 
pumping function of P-gp is oriented from the blood to the liquor, in contrast at the BBB endothelial 
cells P-gp mediates the transport of its substrates into the opposite direction, towards the blood. 
Therefore , we compared the AUC ratio of quinidine for CSF (in the lateral ventricle) to blood and for 
brain parenchyma (STR) to blood in presence and absence of PSC-833 in the middle aged animals. 
The AUCLV/AUCblood showed a 2.03 fold increase and the AUCSTR/AUCblood displayed a 3.08 fold 
increase after PSC-833 treatment (Figure 5 C,D). These data suggest that although the orientation is 
different there are other mechanisms too, playing a role in quinidine disposition in the CNS. 
 
In summary, our results indicate a moderate difference in the BBB permeability between the young 
and old subjects for our P-gp substrate, quinidine in control animals. However, if the transporter is 
chemically blocked by a specific inhibitor the increase of brain exposure becomes higher in young 
than in elderly subjects. These findings are in accordance with the lower expression level of P-gp in 
elderly animals (our unpublished data) and reduced P-gp function reported in aged humans 
(Toornvliet et al., 2006, Bartels et al., 2009). The blockade of lower number of efflux transporter 
proteins results in a lower increase in the BBB permeation for quinidine in old rats compared to the 
young adults.  
3.6 SPECT imaging 
 
The brain exposure to MIBI in presence and absence of P-gp inhibitor was evaluated in one-one 
representative animal by SPECT imaging. The radioactivity in the brain increased both in young and in 
old rats after administration of P-gp –inhibitor as it is seen in the MIBI efflux curves (Figure 6). At the 
first timepoint the control exposure is higher in young rats suggesting a slower kinetics, but after 24-
36 min the MIBI level becomes higher in the brain of the middle aged animal indicating a higher 
leakage of the BBB in the old subject. The order of P-gp functionality in young and old animals is the 
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following: young control > old control > old PSC-833 = young PSC-833 as it is seen in Figure 6. These 
results indicate a higher transcellular permeability of the BBB endothelial cells for P-gp substrates in 
advanced age and a reduced P-gp expression or function with aging leading to similar brain exposure 
of MIBI to young subjects after chemical blocking of the transporter. 
 
4. Discussion 
 
Our study described here, focused on the investigation ofalteration of the different cerebrovascular 
parameters and factors with physiological aging. Our model animals were male Wistar rats. They 
were housed in pairs in their home cages. The keeping was at least 14-16 months long at our animal 
facility and during this period the animals have ad libitum access to standard laboratory food and tap 
water. According to the observations of Sengupta, 2013, the age of the rats can be correlated with 
the age of humans. In that study a comparison between Rattus Norvegicus and humans was made. 
The study also observed age-dependent correlations between the days of rat age and the years of 
human age. Different other methods of calculation for comparing the human and rat age have also 
been published.  However, we have not been able to identify any study on the comparison of 
different rat strains, although it is well known that the bodyweight and body size development are 
very variable between different rat strains. On the basis of data available (Sengupta 2013) we 
conclude that our experimental rats were middle aged (approximately 50- year old in humans). 
Our results confirmed the data of the literature concerning the effect of aging on ultrastuctural 
changes in the brain microvasculature (Hunziker et al., 1978, Kacem et al., 1998) and the GFAP and P-
gp expression in the BBB (Peinado et al., 1998, Tigges et al., 1995). On the basis of these results our 
middle aged male Wistar rats seems to be appropriate model animals of healthy, physiological aging. 
To charachterize the P-gp function relative to aging a previously validated probe substrate, quinidine 
(Sziráki et al., 2011, Sziráki et al., 2013) was used in microdialysis experiments and [99mTechnetium]-2-
methoxy-isobutyl-isonitrile (Tc-MIBI) (Piwnica-Worms & Sharma 2010) was applied as a SPECT 
radiotracer. Both compounds displayed a low brain exposure in control animals and an enhanced 
brain level after P-gp inhibition. A slower distribution of MIBI can be seen in aged animals then in 
young ones in the first some minutes after treatment (probably due to the decreased blood flow in 
aged rat), but 24 min after the intravenous injection a higher brain penetration was reached in the 
middle aged rat. The brain exposure to MIBI is influenced by several factors like i) regional blood flow 
ii) cellular mitochondrial number per unit organ mass ii) cellular membrane potential iii) 
mitochondrial membrane potential iv) cell membrane lipid bilayer fluidity v) cellular Na/H antiporter 
activity and vi) P-gp efflux pump expression and function (Piwnica-Worms et al., 1990, Kurata et al., 
2015) . It has been described that the cerebral blood flow value is smaller in old subjects (Jefferson et 
al., 2017) than is young ones, therefore and due to an increased thickness of the basal lamina and 
capillary walls (including cell membrane thickness increase) and the astrocyte endfeet, MIBI inflow 
slowers in old animals. In microdialysis study, the control level of quinidine is higher in old than in 
young adult rats as it is seen from the AUC values (Figure 5 A, C). However, these values are 
generated from a 240 min period of time of concentration-time profiles which includes the 
absorption, distribution and also the elimination phases of quinidine both in the brain parenchyma 
(STR) and in the cerebrospinal fluid (LV). The concentration differences are higher at the later 
timepoints indicating a slower elimination in old rats. 
 
Immunostainings, ultrastructural, microdialysis and SPECT results taken together suggest that there 
are many remarkable differences in the structure and function of the blood-brain barrier in young 
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and old rats. These differences can be detected at the level of endothelial cells, astrocytes, tight 
junctions, basal membrane and efflux transporters. Several structural and morphological alterations 
lead to a stronger protection of the brain with aging, while other domains like P-gp downregulation 
and lower expression of tight junction proteins result in higher BBB permeability in aged subjects. 
The paracellular permeability of BBB seems to be higher and the transcellular transport is increased 
due to the reduced P-gp function with aging which can be a starting point of the influx of xenobiotics 
and different dangerous endogenous and exogenous compounds to the brain. To decide whether the 
increasing BBB leakage initiate or enforce the serious events of age-related neurodegenerative 
processes further studies are needed in animals with at an even more advanced age. Studies focusing 
on the analysis of the changes in cognitive function and behavioral performance of middle aged 
Wistar rats are warranted. Environmental factors playing an important role in the effect of aging on 
our mental health should also be considered.These factors, such as the effect of physical activity, 
caloric restriction or cadmium intake of smokers should also be taken into account and studied in 
details in the future.  
Our present study has shed light on age-related differences in the BBB and also pointed out the 
complexity of the topic. 
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